| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-12 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-11 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-10 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-10 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-10 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-09 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-09 |